FDA sets review date for SpinalMotion's artificial disc

05/8/2013 | MassDevice.com (Boston)

An FDA panel will meet on July 24 to evaluate SpinalMotion's premarket approval application for the Kineflex/C system. The metal-on-metal total disc replacement device, which is already available in Europe, is intended for one-level repair of the intervertebral disc in patients who have undergone single-level discectomy for lumbar degenerative disc disease.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX